Relating to the provision of an abortion-inducing drug.

SB 2625 (Texas Health and Safety Code §171.063) restricts who may provide abortion-inducing drugs by requiring that only a physician physically present in Texas can administer them during an in-person examination. It mandates a follow-up visit within 14 days to confirm pregnancy termination and assess blood loss. The bill also applies to out-of-state physicians providing abortion-related consultations, adding new restrictions under the Occupations Code. These provisions directly affect physicians, patients seeking abortion care, and out-of-state medical professionals. The law takes effect September 1, 2025.